Showing results (451-460 of 845) with videos related to

Sort By:
Pageof 85
Journal of the National Cancer Institute|April 28, 2022
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical TrialsMathew Hall, Vaishali A Krishnanandan, Matthew C Cheung, et al.
Vaccine|July 18, 2001
Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic miceB J Zheng, M H Ng, L F He, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Increased bone mineral density in patients with chronic hypoparathyroidismFredriech K W Chan, Sau-Cheung Tiu, Kin-Lam Choi, et al.
International Journal of Dermatology|February 22, 2012
Improving adherence to safe prescription guidelines for Dapsone: harnessing an enhanced electronic medical records system and a team approachChing Yin Neoh, Elizabeth A L Tian, Cindy Choi, et al.
Human Reproduction (Oxford, England)|February 27, 2020
Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutationsJoseph H Lipton, Mahdi Zargar, Ellen Warner, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World ExperienceYue Jennifer Du, Rui Fu, Justin T Levinsky, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 4, 2011
Hypertrophic pyloric stenosis in a newborn: a diagnostic dilemmaShannon M Chan, Edwin K W Chan, Winnie C W Chu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2021
Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over timeSasha Thomson, Noah Witzke, Bishal Gyawali, et al.
Bone Marrow Transplantation|April 3, 2001
A fludarabine-based conditioning regimen for severe aplastic anemiaK W Chan, C K Li, L L Worth, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World DataBrandon Lu, Erind Dvorani, Lena Nguyen, et al.
Pageof 85